Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-013118
Filing Date
2023-05-08
Accepted
2023-05-08 21:39:59
Documents
2
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1444
2 poa_bode.htm EX-24 6731
  Complete submission text file 0001437749-23-013118.txt   9733
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRIBUNE PUBLISHING COMPANY 202 W. FIRST STREET LOS ANGELES CA 90012
Business Address
Bode John B (Reporting) CIK: 0001612084 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 23899703